B

BioLife Solutions
D

BLFS

21.190
USD
-0.34
(-1.57%)
Market Closed
Volume
9,838
EPS
-0
Div Yield
-
P/E
-112
Market Cap
1,007,821,213
Related Instruments
NEOUSD
NEOUSD
0.04264
(0.84%)
5.13474 USD
ALNY
ALNY
-2.55
(-0.82%)
309.82 USD
C
CPHI
-0.02400
(-1.36%)
1.74600 USD
G
GH
-1.460
(-2.89%)
49.100 USD
N
NEO
0.05000
(0.72%)
7.00000 USD
PODD
PODD
1.57
(0.52%)
303.27 USD
P
POLA
0.01000
(0.57%)
1.76000 USD
More
News

Title: BioLife Solutions

Sector: Healthcare
Industry: Medical Instruments & Supplies
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.